南旋控股(01982.HK)年度扭虧為盈至1.57億港元
格隆匯 6 月 26日丨南旋控股(01982.HK)公告,截止2020年3月31日止年度,公司實現收入44.8億港元,同比增2.8%;公司擁有人應占淨利1.57億港元,去年則虧損2.98億港元,扭虧為盈;每股盈利6.89港仙;每股中期股息4.3港仙。
COVID-19隨後蔓延至全球爆發令各地消費急挫,訂單需求受到打亂。為此,集團即時檢視旗下業務所面臨的各項業務風險並作出相應決策,當中包括重組針織鞋面及針織鞋業務。縱然此舉對集團的財務業績帶來短期的負面影響,然而我們相信,是項重組將有助於全球局勢迴歸正常時為股東帶來更佳回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.